As of Friday, January 09, Rigel Pharmaceuticals, Inc.’s RIGL share price has dipped by 5.01%, which has investors questioning ...

As of Wednesday, December 31, Vanda Pharmaceuticals Inc.’s VNDA share price has surged by 34.23%, which has investors questioning if this is right time to sell.

BridgeBio Pharma (BBIO) has priced its private offering of $550M aggregate principal amount of 0.75% convertible senior notes ...

If you are wondering whether Vertex Pharmaceuticals' current share price reflects its long term potential, a useful starting ...

Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

What Happened? Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) fell 5.3% in the afternoon session ...

If you are wondering whether Catalyst Pharmaceuticals' current share price still reflects a good entry point, or if the best ...

A Wells Fargo analyst cut his price target on Ultragenyx stock, though it still implies significant upside from yesterday's closing price. Ultragenyx reported yesterday that two Phase 3 studies failed ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.

Despite additional cost savings in 2026, Pfizer also forecasts that its adjusted earnings per share (EPS) will likely decline ...